
|Articles|June 1, 2014
- Applied Clinical Trials-06-01-2014
- Volume 23
- Issue 6
ACT cover
S
Advertisement
Cover
Articles in this issue
about 12 years ago
Three-Pronged Approach to Optimizing Trial Monitoringabout 12 years ago
Half of All Drugs Today are Developed Through Collaborationsabout 12 years ago
Event Examines Key Clinical Trial Adaptation Trendsabout 12 years ago
Policymakers Seek New Ways to Streamline R&D and Approvalabout 12 years ago
Rebranding 'Risk-Based Monitoring'about 12 years ago
Engaging Tomorrow's Volunteers Through Museum Learningabout 12 years ago
Questions and Hopes on New EU Drug Legislationabout 12 years ago
The Metrics Behind High Performing Study Startupsabout 12 years ago
Enhancing Trial Enrollment Through 'Goal Programming'about 12 years ago
Shifting Monitoring Paradigms: Challenges and OpportunitiesAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
3
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
4
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
5




